MedPath

ASA Levels in TEP and Lichtenstein Repair Patients

Not Applicable
Conditions
Hernia, Inguinal
Registration Number
NCT03355950
Lead Sponsor
Ankara City Hospital Bilkent
Brief Summary

The purpose of this study is to determine and compare the possible affects of two different inguinal hernia repair technique (TEP and Lichtenstein) on serum ASA levels.

Detailed Description

Antisperm antibody levels are thought to be indirect indicators of spermatic duct injuries. The investigators' ultimate goal is to draw a conclusion about the effect of the type of surgery on spermatic duct integrity. The investigators are going to collect serum samples from inguinal hernia patients before and after surgery. The investigators aim to assess the effect of surgery on antisperm antibody levels of patients who undergo Licthenstein and TEP repair. Preoperative antisperm antibody levels will serve as control levels for each patient group.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
160
Inclusion Criteria
  • to accept the terms of the randomization and all study
  • to have unilateral inguinal hernia and set for an inguinal hernia repair
  • to be a father
Exclusion Criteria
  • to have any kind of autoimmune disorders
  • any kind of infertility history
  • to have a history of inguinal and/or genital surgery and/or trauma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from baseline Anti-sperm antibody levels after inguinal hernia surgeryThree months for each patient

Samples will be collected before hernia surgery and three months after surgery

Secondary Outcome Measures
NameTimeMethod
Comparison of Anti-sperm antibody levels between inguinal hernia patients who have undergone laparoscopic totally extraperitoneal repair and Lichtenstein repair techniques2 years anticipated

Trial Locations

Locations (1)

Ankara Numune Training and Research Hospital

🇹🇷

Ankara, Turkey

Ankara Numune Training and Research Hospital
🇹🇷Ankara, Turkey
Selami Ilgaz Kayılıoğlu, MD
Contact
+905332036595
kayilioglu@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.